Skip to content

Disturbed Blood Flow Induces Endothelial Dysfunction in Severe Chronic Obstructive Pulmonary Disease

Disturbed Blood Flow Induces Endothelial Dysfunction in Severe Chronic Obstructive Pulmonary Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03004352
Enrollment
27
Registered
2016-12-28
Start date
2015-04-30
Completion date
2015-05-31
Last updated
2016-12-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Brief summary

The aim of the study is to determine if increased retrograde shear would further deteriorate the already impaired vascular function in severe COPD patients.

Interventions

OTHERretrograde flow

Two pneumatic cuffs were placed on the experimental arm, one on the lower forearm, and the other on the upper arm. Two cuffs were simultaneously inflated for 20 minutes. The distal cuff was inflated to 75 mm Hg and the proximal cuff was inflated to 40 mm Hg. The contralateral (control) arm was cuff free during this intervention.

OTHERoxygen

Supplemental 100% oxygen administered through a nasal cannula.

Sponsors

University of Split, School of Medicine
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* COPD * chronic hypoxemia

Exclusion criteria

* an acute exacerbation, active respiratory infection or infection of other localisation 6 weeks prior to the visit * relevant coexisting lung disease such as interstitial lung disease, cancer, renal failure, thromboembolic disease or major cardiovascular event during the previous year * informed consent not provided or inability to comply with the study protocol

Design outcomes

Primary

MeasureTime frame
Change from Baseline Brachial Artery Diameter at 10, 20 and 25 minutes0,10, 20 and 25 minutes
Change from Baseline Microparticle Count at 20 minutes0 and 20 minutes

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026